Key result
ICD therapy in women is linked to higher complication rates and greater psychological distress than men.
Why the study?
Women with implantable cardioverter defibrillators experience sex-specific postimplantation challenges, psychological distress, and diminished quality of life, yet remain underrepresented in clinical trials and receive ICD therapy less often than men.
Women with implantable cardioverter defibrillators face higher rates of complications, psychological distress, and body image concerns alongside trial underrepresentation, underscoring the need for tailored sex-specific and psychosocial interventions.
Answers are grounded in this paper and cite their sources.
Women with ICDs may need tailored counseling; leaves open need for sex-specific prospective trials.
Although cardiovascular disease remains the leading cause of death in women globally, it is underdiagnosed and undertreated. Implantable cardioverter defibrillators (ICDs) reduce the risk of sudden cardiac death, but many women report diminished quality of life and avoidance behaviors and present sex-specific challenges postimplantation. Women have higher rates of concern, comorbidities, psychological distress, and anatomic factors that can affect the outcomes of ICD therapy. Women experience more ICD-related complications, psychological distress, and body image concerns, which can adversely affect their quality of life and ICD implant adjustments. Anatomic differences and comorbidities may contribute to these issues. Despite these factors, women remain underrepresented in clinical trials and receive ICD therapy less often than men. Psychosocial interventions such as education, cognitive-behavioral therapy, and support groups have shown promise in improving outcomes, but further research is required to assess their effectiveness. Although current interventions show potential, persistent disparities in utilization and research underscore the need for sex-specific strategies. This article explores sex-specific challenges and outcomes associated with ICD therapy in women, and highlights opportunities for tailored interventions to improve quality of life, sexual health, and well-being.
No takes yet. Share an insight, caveat, or question.
Viancha et al. (2026) conducted a review in Cardiovascular disease requiring implantable cardioverter defibrillators in women. Implantable cardioverter defibrillator (ICD) therapy and psychosocial interventions was evaluated on Quality of life, psychosocial adaptation, and ICD-related complications. Implantable cardioverter defibrillator therapy in women is associated with higher rates of complications, psychological distress, and body image concerns compared to men.
Synapse has enriched 10 related papers. Consider them for comparative context: